SNORA70D

Across TCGA pan-cancer cohorts, SNORA70D RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SNORA70D data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher SNORA70D RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORA70D expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

BLCA, ACC, and UCS are the cancer types where SNORA70D RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	IV	0.091	0.478	<.001	90	view →
ACC	DFS	Tertile	All	0.010	0.624	<.001	81	view →
UCS	DFS	Tertile	All	0.122	0.539	<.001	54	view →
MESO	DFS	Tertile	All	0.139	0.510	.004	36	view →
LUSC	OS	Tertile	III,IV	0.001	0.665	<.001	36	view →
OV	OS	Quartile	IV	0.437	0.820	<.001	20	view →
KIRC	DFS	Tertile	IV	0.185	0.534	.017	18	view →
UCEC	DFS	Tertile	III,IV	0.099	0.584	.043	18	view →
LIHC	DFS	Tertile	All	0.225	0.562	.008	18	view →
ESCA	OS	Tertile	IV	0.243	0.738	.024	9	view →
LAML	DFS	Median	All	0.647	0.497	.028	6	view →
STAD	OS	Quartile	III,IV	0.213	0.537	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SNORA70D–BLCA (DFS)

Open the BLCA breakdown →